385
Participants
Start Date
April 30, 2007
Primary Completion Date
August 31, 2008
Study Completion Date
September 30, 2008
Drospirenone/Ethinylestradiol/Methyltetrahydrofolate
0.020 mg ethinylestradiol with 3.0 mg drospirenone and 0.451 mg L-5-methyltetrahydrofolate (L-5-MTHF)
Drospirenone/Ethinylestradiol (Yaz)
0.020 mg ethinylestradiol with 3.0 mg drospirenone
Columbia University Medical Center, New York
SNBL Clinical Pharmacology Center, Inc., Baltimore
Lyndhurst Gynecologic Associates, Winston-Salem
AAIPharma, Inc., Morrisville
Coastal Carolina Research Center, Mt. Pleasant
New Orleans Center for Clinical Research, Knoxville
Medical Center for Clinical Research, San Diego
Orange County Clinical Trials, Anaheim
NorthWest Kinetics, Tacoma
Lead Sponsor
Bayer
INDUSTRY